am 580 has been researched along with Carcinoma, Anaplastic in 1 studies
Am 580: a selctive retinoic acid receptor (alpha) agonist; structure given in first source
4-{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid : An amidobenzoic acid obtained by formal condensation of the carboxy group of (5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)benzoic acid with the anilino group of 4-aminobenzoic acid. A selective RARalpha agonist.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tanabe, K | 1 |
Utsunomiya, H | 1 |
Tamura, M | 1 |
Niikura, H | 1 |
Takano, T | 1 |
Yoshinaga, K | 1 |
Nagase, S | 1 |
Suzuki, T | 1 |
Ito, K | 1 |
Matsumoto, M | 1 |
Hayashi, S | 1 |
Yaegashi, N | 1 |
1 other study available for am 580 and Carcinoma, Anaplastic
Article | Year |
---|---|
Expression of retinoic acid receptors in human endometrial carcinoma.
Topics: Antineoplastic Agents; Benzoates; Carcinoma; Cell Proliferation; Endometrial Hyperplasia; Endometria | 2008 |